Portal de investigación
Desarrollo de nuevos moduladores multidiana de receptores nucleares y biomarcadores lipídicos para el tratamiento del síndrome metabólico y las comorbilidades asociadas.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity
Marques, Patrice; (...); Cabedo, Nuria
Article. 10.1016/j.phrs.2022.106638. 2023
Synthesis of 2-(3-aminopropyl)benzopyrans as potential antipsychotic agents targeting D2/D3 and 5-HT2A receptors
Bernabeu-Sanchis Á; (...); Cabedo N
Article. 10.1016/j.bmc.2025.118300. 2025
Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer
García, A; (...); Cortes, D
Article. 10.1039/d3md00385j. 2023
